Telomeres and the Danger of Cellular Senescence

Ever since I first became aware of the Hayflick Limit (some 20+ years ago) I have been occupied by what I see as a possible conflict between differing philosophies.

Telomeres are a central biological mechanism associated with skin aging. These nucleotide sequences are located at the ends of chromosomes, acting as protective caps that preserve genomic stability during cellular replication. With each round of mitosis, however, telomeres progressively shorten. When they reach a critically short length, the cell enters into a state of replicative senescence or apoptosis – a constraint first described by Leonard Hayflick and now bearing his name.

This biological reality is of particular relevance in tissues with high cellular turnover. Our epidermis is an example of a continuously renewing tissue in which keratinocytes are generated from basal stem cells before migrating through the epidermal layers to ultimately being shed at the surface. This ongoing renewal is essential for maintaining barrier integrity.

The Hayflick Limit and telomere attrition have increasingly become a topic of discussion within dermatology and cosmetic science. A variety of strategies are being explored to mitigate the consequences of telomere shortening: antioxidant systems, anti-inflammatory approaches, and compounds that may influence telomerase activity.

This raises an interesting question within the context of cosmetic dermatology. For several decades, a significant portion of anti-ageing skincare strategies has been based on the deliberate stimulation of accelerated epidermal renewal as their central anti-aging strategy – through daily chemical exfoliation, retinoid signalling and other interventions designed to increase keratinocyte turnover. These strategies are widely promoted as ‘anti-aging’ because they produce faster renewal and visible short-term improvement in skin texture.

Consider: every forced renewal cycle requires an additional cellular division.

To be clear: the concern here is not with episodic interventions performed by the qualified technician in-clinic, such as our Alex Herbal Peel which is a treatment leading to rapid skin renewal. I am referring to the daily, chronic application of consumer products specifically formulated to maintain a state of accelerated epidermal renewal indefinitely.

From a telomere biology perspective, the question follows logically: does chronically forcing accelerated turnover contribute to faster telomere attrition in the cells responsible for renewal?

I acknowledge, there are other causes for telomere attrition such as oxidative stress. Furthermore, the skin has in-built protective mechanisms: basal keratinocytes retain some protective telomerase activity and increased shedding is, at least initially, absorbed by the transit-amplifying cell pool. However, a condition of chronic, repeated stimulation over years will ultimately draw on the cell pool more than baseline would.

In other words, some anti-aging strategies may improve the immediate appearance of the skin at the potential cost of shortening the functional lifespan of the cellular system that produces that improvement.

This creates potential tension at the heart of anti-aging formulation strategy:  Should the primary objective be to push the skin to renew faster, or to maintain cellular function and biological equilibrium so that the cells remain viable for longer?

Exploring this question may help shift part of the skin longevity discussion from attempts to repair the consequences of cellular ageing toward strategies aimed at preserving the biological conditions that allow skin cells to function optimally for as long as possible.  Again, this is not an argument against clinical procedures performed by qualified technicians in a professional environment but it may be worth asking whether some of our current practices are contributing to the problem in the first place.

At OmniDerm, our approach for the last three decades has been that barrier integrity, oxidative stress reduction, and reduction of inflammation may ultimately be more aligned with long-term skin health and quality than repeatedly forcing accelerated renewal.

Author: Paul Fister, B.Bus (Mktg), Formulation Chemist, Member ASCC | OmniDerm